Elicio Therapeutics, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Elicio Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $2.02M, a 565.35% increase year-over-year.
- Elicio Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $835.00K, a 83.50% decline year-over-year.
- Elicio Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $303.00K.
- Elicio Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $5.06M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-06-30 | $2.02M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $835.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $303.00K 10-Q · filed 2024-11-13 | |
| 2024-03-31 | $5.06M 10-Q · filed 2025-11-13 | |
| 2021-06-30 | $6.00K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |